HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Veli K. Topkara Nicholas C. Dang Fabio Barili Timothy P. Martens Faisal H. Cheema Hasmet Bardakci Ali Vefa Ozcan Yoshifumi Naka Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Topkara, V. K. Articles by Naka, Y. Search for Related Content PubMed PubMed Citation Articles by Topkara, V. K. Articles by Naka, Y. Related Collections Mechanical Circulatory Assistance Transplantation - heart

J Thorac Cardiovasc Surg 2006;131:1190-1191
© 2006 The American Association for Thoracic Surgery

Brief Communication

Ventricular assist device use for the treatment of acute viral myocarditis

Columbia University College of Physicians and Surgeons, Department of Cardiothoracic Surgery, New York, NY

Received for publication July 26, 2005; accepted for publication August 3, 2005.

^_* Address for reprints: Yoshifumi Naka, MD, PhD, Herbert Irving Assistant Professor of Surgery, Columbia University, College of Physicians and Surgeons, Director, Mechanical Circulatory Support Program, New York-Presbyterian Hospital, Columbia University Medical Center, 177 Fort Washington Avenue, Milstein Hospital 7GN-435, New York, NY 10032 (Email: yn33@columbia.edu).

The first 20% of the full text of this article appears below.

Acute viral myocarditis is a rare condition and associated with high mortality due to the rapid development of heart failure. Ventricular assist devices (VADs) have become a life-saving approach for patients with acute viral myocarditis who are otherwise refractory to the aggressive medical therapy. ^1,2 We reviewed our institutional experience to evaluate the use of VADs as a treatment option for viral myocarditis.

Patients and Methods

From January 1995 to March 2005, 11 patients underwent VAD implantation (left VAD [LVAD] in 10, biventricular assist device [BIVAD] in 1) for acute viral myocarditis at Columbia-Presbyterian Medical Center. Patients were evaluated with regards to demographics, presenting symptoms, histological manifestations, and electrocardiographic findings. Outcome variables included bridge-to-transplantation rate and long-term survival. Data was collected by retrospective chart review.

Results

The mean age of the population was 33.8 ± 14.2 years. None of the patients had a previous history of cardiac disease. Prodromal symptoms preceding the onset of myocarditis included flulike symptoms, chest pain, syncope, and varicella . . . [Full Text of this Article]

This article has been cited by other articles:

				R. S. Gardner and A. L. Clark 8 Infective and infiltrative causes of heart failure Oxford Textbook of Heart Failure, January 1, 2011; 1(1): med-9780199577729-chapter - med-9780199577729-chapter. [Abstract] [Full Text]

				S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628. [Full Text]